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Pragmatic trials determine the effects of an intervention
under the usual conditions in which it will be applied.
Databases of electronic health records (EHR), such as
the General Practice Research Database (GPRD), provide
a unique opportunity to conduct large scale pragmatic
trials. This paper describes the infrastructure as being
implemented for two feasibility pragmatic trials within
GPRD. Clinicians willing to participate first need to
complete a web-based training (covering both the study
protocol and key aspects of good clinical practice). The
EHR database will be searched for potentially eligible
patients and a list including codes of potentially eligible
patients and those of clinicians who completed the
training will be compiled. This list will then be sent,
using secure file transfer, to the desktop computer of
the clinician. When a potentially eligible patient then
visits the clinician for a consultation, a flag at the clini-
cian’s computer screen may then appear, notifying of
the possibility to recruit. This flag provides a link to the
study website, including the consent form and patient
information sheet. After obtaining consent, the patient
can then be randomised (using the website) and a pre-
scription for the randomly allocated treatment can then
be issued by the clinician. Daily downloads of the anon-
ymous EHR records from the clinician’s office to the
central research site will allow the reporting of sus-
pected side-effects. The trial database can be compared
periodically to the full GPRD for purposes of fraud
detection and comparison of the trial patients to the
‘real-life population of users. GPRD is linked periodically
to other NHS datasets (including hospital episode statis-
tics, disease registries and death certificates), using an
anonymous process through a trusted third party. This
linkage allows an anonymous long-term data collection
of major clinical outcomes with no intrusion. It is possi-
ble to contact the clinician in order to confirm the data
as provided by the various sources. One trial concerns a
comparison of two statins by randomising patients with
primary hypercholesterolaemia and high CVD risk
between simvastatin and atorvastatin (with 300 patients;
ISRCTN33113202). The other trial concerns a compari-
son of antibiotic to no treatment in patients with a
COPD exacerbation and non-purulent sputum (with 150
patients; ISRCTN72035428).
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